Nonpartisan civic infrastructure

S. 4348

BillFederalSenateFloor Consideration

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

About This Bill

Floor Vote

Congress

117th (2021–2023)

Introduced

May 26, 2022

Sponsor

Sen. Patty MurrayD

Cosponsors (1)

0D 1R

View PDF ↗

Summary Full Text Comments Annotations

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

Introduced in Senate (2022/05/26) · May 26, 2022Congress.gov ↗Reported to Senate (2022/07/13) · Jul 13, 2022Congress.gov ↗

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position

Add a comment

to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.